{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:51:19Z","timestamp":1780685479879,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC-IG 2018 Id.22143"],"award-info":[{"award-number":["AIRC-IG 2018 Id.22143"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC-IG 2017 Id.20564"],"award-info":[{"award-number":["AIRC-IG 2017 Id.20564"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["(TIGET 2016 core grant no. C1"],"award-info":[{"award-number":["(TIGET 2016 core grant no. C1"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41375-023-02009-5","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T15:06:38Z","timestamp":1693235198000},"page":"1994-2005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease"],"prefix":"10.1038","volume":"37","author":[{"given":"Carolina","family":"Caserta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-142X","authenticated-orcid":false,"given":"Silvia","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Barcella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8422","authenticated-orcid":false,"given":"Grazia","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-2884","authenticated-orcid":false,"given":"Matteo Maria","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Zonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"D\u2019Angi\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-042X","authenticated-orcid":false,"given":"Angelo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-1536","authenticated-orcid":false,"given":"Orietta","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-4528","authenticated-orcid":false,"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-4718","authenticated-orcid":false,"given":"Bernhard","family":"Gentner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"2009_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.23736\/S0026-4806.20.07031-7","volume":"111","author":"F Lanza","year":"2020","unstructured":"Lanza F, Maffini E, Saraceni F, Massari E, Rondoni M, Daghia G, et al. New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia. Minerva Med. 2020;111:478\u201390. https:\/\/pubmed.ncbi.nlm.nih.gov\/32955830\/.","journal-title":"Minerva Med"},{"key":"2009_CR2","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood. 2005;106:3760\u20137.","journal-title":"Blood."},{"key":"2009_CR3","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.leukres.2012.08.019","volume":"36","author":"E Liew","year":"2012","unstructured":"Liew E, Atenafu EG, Schimmer AD, Yee KWL, Schuh AC, Minden MD, et al. Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen. Leuk Res. 2012;36:1517\u201320. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0145212612003529.","journal-title":"Leuk Res"},{"key":"2009_CR4","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.5045\/br.2020.S004","volume":"55","author":"IS Kim","year":"2020","unstructured":"Kim IS. Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation. Blood Res. 2020;55:S19\u201326. https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2020.S004.","journal-title":"Blood Res"},{"key":"2009_CR5","first-page":"1","volume":"16","author":"N Sikich","year":"2016","unstructured":"Sikich N, Soulodre C, Sadasook N, Sleeman A, Verhey J. Citation Health Quality Ontario. Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review. Ont Health Technol Assess Ser. Ont Health Technol Assess Ser. 2016;16:1\u201352.","journal-title":"Ont Health Technol Assess Ser"},{"key":"2009_CR6","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","volume":"125","author":"JJM van Dongen","year":"2015","unstructured":"van Dongen JJM, van der Velden VHJ, Br\u00fcggemann M, Orfao A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: Need for sensitive, fast, and standardized technologies. Blood. 2015;125:3996\u20134009. https:\/\/pubmed.ncbi.nlm.nih.gov\/25999452\/.","journal-title":"Blood"},{"key":"2009_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275\u201391. https:\/\/doi.org\/10.1016\/j.stem.2014.02.006.","journal-title":"Cell Stem Cell"},{"key":"2009_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.1164266","volume":"322","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322:1377\u201380.","journal-title":"Science."},{"key":"2009_CR9","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1038\/ncomms7604","volume":"6","author":"X Ma","year":"2015","unstructured":"Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015;6:6604 https:\/\/pubmed.ncbi.nlm.nih.gov\/25790293.","journal-title":"Nat Commun"},{"key":"2009_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/2159-8290.CD-19-1059","volume":"10","author":"SM Dobson","year":"2020","unstructured":"Dobson SM, Garc\u00eda-Prat L, Vanner RJ, Wintersinger J, Waanders E, Gu Z, et al. Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs. Cancer Discov. 2020;10:568\u201387.","journal-title":"Cancer Discov"},{"key":"2009_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/0008-5472.BCD-19-0041","volume":"1","author":"E Waanders","year":"2020","unstructured":"Waanders E, Gu Z, Dobson SM, Anti\u0107 \u017d, Crawford JC, Ma X. et al. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia. Blood Cancer Discov. 2020;1:96\u2013111.","journal-title":"Blood Cancer Discov"},{"key":"2009_CR12","doi-asserted-by":"publisher","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science (1979). 2017;357:eaal2380.","journal-title":"Science"},{"key":"2009_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.stem.2012.09.001","volume":"11","author":"ER Lechman","year":"2012","unstructured":"Lechman ER, Gentner B, van Galen P, Giustacchini A, Saini M, Boccalatte FE, et al. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell. 2012;11:799\u2013811. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23142521.","journal-title":"Cell Stem Cell"},{"key":"2009_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ccell.2016.03.015","volume":"29","author":"ER Lechman","year":"2016","unstructured":"Lechman ER, Gentner B, Ng SWK, Schoof EM, van Galen P, Kennedy JA. et al. MiR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells [Cancer Cell 29, (2016) 214-228; February 8]. Cancer Cell. 2016;29:602\u20136.","journal-title":"Cancer Cell"},{"key":"2009_CR15","doi-asserted-by":"publisher","first-page":"58ra84","DOI":"10.1126\/scitranslmed.3001522","volume":"2","author":"B Gentner","year":"2010","unstructured":"Gentner B, Visigalli I, Hiramatsu H, Lechman E, Ungari S, Giustacchini A, et al. Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med. 2010;2:58ra84\u201358ra84. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21084719.","journal-title":"Sci Transl Med"},{"key":"2009_CR16","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1182\/blood-2015-04-639062","volume":"126","author":"Z Li","year":"2015","unstructured":"Li Z, Chen P, Su R, Li Y, Hu C, Wang Y, et al. Overexpression and knockout of miR-126 both promote leukemogenesis. Blood. 2015;126:2005\u201315.","journal-title":"Blood."},{"key":"2009_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nm.4499","volume":"24","author":"B Zhang","year":"2018","unstructured":"Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450\u201362. https:\/\/doi.org\/10.1038\/nm.4499.","journal-title":"Nat Med"},{"key":"2009_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2016.05.007","volume":"29","author":"S Nucera","year":"2016","unstructured":"Nucera S, Giustacchini A, Boccalatte F, Calabria A, Fanciullo C, Plati T, et al. miRNA-126 orchestrates an oncogenic program in B cell precursor acute lymphoblastic leukemia. Cancer Cell. 2016;29:905\u201321.","journal-title":"Cancer Cell"},{"key":"2009_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ccell.2015.12.011","volume":"29","author":"ER Lechman","year":"2016","unstructured":"Lechman ER, Gentner B, Ng SWK, Schoof EM, van Galen P, Kennedy JA, et al. MiR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell. 2016;29:214\u201328.","journal-title":"Cancer Cell"},{"key":"2009_CR20","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","volume":"74","author":"DC de Leeuw","year":"2014","unstructured":"de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Jan Schuurhuis G, et al. Attenuation of microRNA-126 expression that drives CD34+38- stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74:2094\u2013105. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24477595.","journal-title":"Cancer Res"},{"key":"2009_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2010.07.009","volume":"399","author":"R Harnprasopwata","year":"2010","unstructured":"Harnprasopwata R, Hab D, Toyoshimaa T, Lodishc H, Tojoa A. Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126. Biochem Biophys Res Commun. 2010;399:117\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"2009_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1261\/rna.1731910","volume":"16","author":"AM Monteys","year":"2010","unstructured":"Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, et al. Structure and activity of putative intronic miRNA promoters. RNA. 2010;16:495\u2013505.","journal-title":"RNA."},{"key":"2009_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile A, Migliara A, Capasso P, Biffi M, Cittaro D, Naldini L, et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell. 2016;167:219\u2013232.e14. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0092867416312363?via%3Dihub.","journal-title":"Cell"},{"key":"2009_CR24","doi-asserted-by":"crossref","unstructured":"Lei H, Quelle FW. FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage. Mol Cancer Res. 2009;7:1294\u2013303. http:\/\/mcr.aacrjournals.org\/.","DOI":"10.1158\/1541-7786.MCR-08-0531"},{"key":"2009_CR25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ni.2615","volume":"14","author":"E Laurenti","year":"2013","unstructured":"Laurenti E, Doulatov S, Zandi S, Plumb I, Chen J, April C, et al. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol. 2013;14:756\u201363.","journal-title":"Nat Immunol"},{"key":"2009_CR26","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1073\/pnas.1413383112","volume":"112","author":"JS McClellan","year":"2015","unstructured":"McClellan JS, Dove C, Gentles AJ, Ryan CE, Majeti R. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages. Proc Natl Acad Sci USA. 2015;112:4074\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2009_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 2011;471:235\u201341. https:\/\/pubmed.ncbi.nlm.nih.gov\/21390130\/.","journal-title":"Nature"},{"key":"2009_CR28","doi-asserted-by":"publisher","first-page":"E4030","DOI":"10.1073\/pnas.1702489114","volume":"114","author":"O Schwartzman","year":"2017","unstructured":"Schwartzman O, Savino AM, Gombert M, Palmi C, Cario G, Schrappe M, et al. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome. Proc Natl Acad Sci USA. 2017;114:E4030\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/28461505\/.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2009_CR29","doi-asserted-by":"crossref","unstructured":"Oshima K, Khiabanian H, da Silva-Almeida AC, Tzoneva G, Abate F, Ambesi-Impiombato A, et al. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2016;113:11306\u201311. https:\/\/pubmed.ncbi.nlm.nih.gov\/27655895\/.","DOI":"10.1073\/pnas.1608420113"},{"key":"2009_CR30","doi-asserted-by":"crossref","unstructured":"Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, et al. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun. 2014;5. https:\/\/pubmed.ncbi.nlm.nih.gov\/24662245\/.","DOI":"10.1038\/ncomms4469"},{"key":"2009_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ng.2558","volume":"45","author":"JA Meyer","year":"2013","unstructured":"Meyer JA, Wang J, Hogan LE, Yang JJ, Dandekar S, Patel JP, et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet. 2013;45:290\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/23377183\/.","journal-title":"Nat Genet"},{"key":"2009_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1182\/blood.2019002220","volume":"135","author":"B Li","year":"2020","unstructured":"Li B, Brady SW, Ma X, Shen S, Zhang Y, Li Y, et al. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood. 2020;135:41\u201355. https:\/\/pubmed.ncbi.nlm.nih.gov\/31697823\/.","journal-title":"Blood"},{"key":"2009_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature09733","volume":"469","author":"F Notta","year":"2011","unstructured":"Notta F, Mullighan CG, Wang JCY, Poeppl A, Doulatov S, Phillips LA, et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature. 2011;469:362\u20137.","journal-title":"Nature."},{"key":"2009_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger S, \u00d6zdemir EZ, Ziegenhain C, Tiedt S, Castro Alves C, Grunert M, et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell. 2016;30:849\u201362.","journal-title":"Cancer Cell"},{"key":"2009_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s43018-021-00219-3","volume":"2","author":"VA Turati","year":"2021","unstructured":"Turati VA, Guerra-Assun\u00e7\u00e3o JA, Potter NE, Gupta R, Ecker S, Daneviciute A, et al. Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia. Nat Cancer. 2021;2:835\u201352. https:\/\/www.nature.com\/articles\/s43018-021-00219-3.","journal-title":"Nat Cancer"},{"key":"2009_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1343","volume":"36","author":"Y Hu","year":"2004","unstructured":"Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D, et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet. 2004;36:453\u201361.","journal-title":"Nat Genet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02009-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:04:41Z","timestamp":1695920681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02009-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2009"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-02009-5","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}